EQRx logo

EQRx

EQRx (Nasdaq: EQRX or EQRXW) is a first-of-a-kind company that is revolutionizing the way medicines are discovered, developed, and brought to people.

eqrx.com
Cambridge, MA

CEO: Alexis Borisy
Arboretum Lead: Jan Garfinkle

IN THE NEWS
March 23, 2022 in EQRx, News Page

EQRx Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Corporate Progress

EQRx, Inc. (Nasdaq: EQRX), a new type of pharmaceutical company committed to developing and delivering innovative medicines to patients at radically lower prices, today reported financial results for the quarter and…
Read More
January 18, 2022 in EQRx, News Page

EQRx Announces Two Lancet Oncology Publications of Positive Phase 3 Results

EQRx, Inc. (Nasdaq: EQRX) a new type of pharmaceutical company committed to developing and delivering important new medicines to patients at radically lower prices, today announced that data from its…
Read More
January 10, 2022 in EQRx, News Page

EQRx Enters Memorandum of Understanding with CVS Health to Create Cost Savings and Improve Patient Access to Innovative Medicines

EQRx, Inc. (Nasdaq: EQRX), a new type of pharmaceutical company committed to developing and delivering important new medicines to patients at radically lower prices, today announced it has entered into…
Read More
December 17, 2021 in EQRx, Home Page, News Page

EQRx Debuts as Publicly Traded Company

CM Life Sciences III (Nasdaq: CMLT, CMLTW, CMLTU), a life science-focused special purpose acquisition company, or SPAC, sponsored by affiliates of Casdin Capital, LLC and Corvex Management LP, and EQRx,…
Read More